Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BYGut microbes

Functionally declining microbiota in chronic disease: beyond taxonomic loss.

  1. 1Division of Biosystems & Biomedical Sciences, College of Health Sciences, Korea University, Seoul, Korea.

Abstract

Microbiota deterioration in modern human populations has been linked to chronic disease, and taxonomic profiling is increasingly used to understand, diagnose, and guide treatment. Yet such profiles do not fully capture disease-relevant microbiota states. I propose functional decline within retained taxa as a distinct axis of microbiota deterioration, complementary to taxonomic loss. Modern environmental pressures can drive not only taxonomic loss but also directional selection toward variants or lineages with reduced host-beneficial function or increased harmful activity. Two mechanistically characterized systems from studies by my group illustrate this process: antibiotic-selected Akkermansia variants with diminished metabolic benefits, and Faecalibacterium pathobionts that promote disease when dominant over beneficial strains, with supporting evidence from atopic dermatitis and pediatric inflammatory bowel disease. Evidence from additional gut taxa suggests that this pattern may extend beyond these two examples. By integrating this hidden axis of functional decline with the well-established axis of taxonomic loss, the proposed two-axis framework could help clarify inconsistent microbiota-disease associations and guide strain-resolved, function-first approaches to microbiota analysis and intervention.

Related

  1. Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease
    Meiling Jin, Lijie Ma, Yuqing Yuan +3
    ViewPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  2. Gut Microbiota Dysbiosis in Advanced Chronic Kidney Disease and Kidney Transplantation: A Narrative Review of Pathophysiological Mechanisms, Implications for Nutritional Status, and Biotic Interventions
    Cyntia Carolina García-Ramírez, Fabiola Martín-del Campo, José Efrén Ortíz-González +2
    NutrientsPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  3. Modulation of microbiota by traditional Chinese medicine in chronic inflammatory airway disease: a systematic review and meta-analysis of animal studies
    Junting Sai, Haixia Li, Liu Chun +4
    Frontiers in immunologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  4. Two functionally distinct amyloid-β intermediates link aggregation pathways to pathology in Alzheimer's disease
    A. Urbanek, A. J. Dear, D. P. Rhodes +14
    bioRxivPreprintCC BY-NC-NDFull textBiophysicsbioRxiv
  5. Faecal microbiota transplantation for treatment of chronic urticaria with recurrent abdominal pain and food allergy
    Li-Quan Wu, MD, Qing-Fen Yuan, MA, Zhi-Chu Qin, MD +6
    Singapore Medical JournalPeer-reviewedCC BY-NC-SAFull text6 citedMolecular biology & gene regulationDOAJ
BibTeX
@article{kim2026functionally,
  title = {{Functionally declining microbiota in chronic disease: beyond taxonomic loss.}},
  author = {Heenam Stanley Kim},
  journal = {Gut microbes},
  year = {2026},
  month = oct,
  doi = {10.1080/19490976.2026.2748134},
  url = {https://europepmc.org/article/MED/42876361},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Functionally declining microbiota in chronic disease: beyond taxonomic loss.
AU  - Heenam Stanley Kim
PY  - 2026
DA  - 2026/10/15
JO  - Gut microbes
DO  - 10.1080/19490976.2026.2748134
UR  - https://europepmc.org/article/MED/42876361
AB  - Microbiota deterioration in modern human populations has been linked to chronic disease, and taxonomic profiling is increasingly used to understand, diagnose, and guide treatment. Yet such profiles do not fully capture disease-relevant microbiota states. I propose functional decline within retained taxa as a distinct axis of microbiota deterioration, complementary to taxonomic loss. Modern environmental pressures can drive not only taxonomic loss but also directional selection toward variants or lineages with reduced host-beneficial function or increased harmful activity. Two mechanistically characterized systems from studies by my group illustrate this process: antibiotic-selected Akkermansia variants with diminished metabolic benefits, and Faecalibacterium pathobionts that promote disease when dominant over beneficial strains, with supporting evidence from atopic dermatitis and pediatric inflammatory bowel disease. Evidence from additional gut taxa suggests that this pattern may extend beyond these two examples. By integrating this hidden axis of functional decline with the well-established axis of taxonomic loss, the proposed two-axis framework could help clarify inconsistent microbiota-disease associations and guide strain-resolved, function-first approaches to microbiota analysis and intervention.
SN  - 1949-0976
SN  - 1949-0984
ER  -